TABLE 1.
Neuroprotective effect of agents tested on the RSCEM.
Treatment | Time of treatment | P50 increment | Reference |
---|---|---|---|
t-PA | 1 hr. | 145% | (14) |
TNK | 1 hr. | 144% | (22) |
NXY-059 | 5 min | 144% | (23) |
Memantine | 1 hr. | 180% | (24) |
Edaravone | 3 hr. | 133% | (25) |
Laser Single 25mW/cm2 | 1 hr. | 108% | (3) |
Laser Double 7.5mW/cm2 |
2 & 5hr. | 68% | Current Study |
Laser Triple 20mW/cm2 | 2, 3 & 4hr. | 245% | Current study |
t-PA: tissue plasminogen activator, TNK: Tenecteplase, NXY: Disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-Oxide